AMENDMENT dated 8 May 2007 of the EXCLUSIVE LICENSE AND SPONSORED RESEARCH AGREEMENT dated 31 October 2005 By and between MEDICAL RESEARCH COUNCIL and OMEROS CORPORATION
Exhibit 10.32
AMENDMENT dated 8 May 2007
of the
EXCLUSIVE LICENSE AND SPONSORED RESEARCH AGREEMENT
dated 31 October 2005
dated 31 October 2005
By and between
MEDICAL RESEARCH COUNCIL and OMEROS CORPORATION
This is an amendment (this “Amendment”) effective 8 May 2007 of the Exclusive License and
Sponsored Research Agreement between Medical Research Council (“MRC”) and Omeros Corporation
(“Omeros”) dated 31 October 2005 (“the Agreement”). All initial capitalized terms used herein
below shall have the same definition as set forth in the Agreement.
Section 2.5 of the Agreement provides for payments for Sponsored Research during each year of
a three year Sponsored Research Term to be paid on a quarterly basis, with twenty five percent
(25%) of the annual amount to be paid each quarter. In as much as the third year of the Sponsored
Research Terms comprises only a ten (10) month Sponsored Research period, not withstanding the
payment schedule set forth in Section 2.5 of the Agreement, Omeros and MRC hereby agree that
payments during the third year of the Sponsored Research Term shall be due and payable as follows:
Quarterly Payment | Amount | Due Date | ||
1st
|
[†] | 1 November 2007 | ||
2nd
|
[†] | 1 March 2008 | ||
3rd
|
[†] | 1 July 2008 | ||
4th
|
[†] | 31 August 2008 |
The total amount of funding for the third year of the Sponsored Research Term [†], as well as
each party’s right to terminate the Agreement early in accordance with the provisions of Section 14
of the Agreement, and all other terms of the Agreement remain unchanged and in force.
† | DESIGNATES PORTIONS OF THIS DOCUMENT THAT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT FILED SEPARATELY WITH THE COMMISSION |
This Amendment is accepted and acknowledged by each party, as of the effective date set forth
herein above, through the signature of its authorized representatives below:
MEDICAL RESEARCH COUNCIL | OMEROS CORPORATION | |||||||||
By:
|
/s/ Xxxx Xxxxx Xxxxxx
|
By: | /s/ Xxxxxxx X. Xxxxxxxxx
|
|||||||
Name:
|
Xxxx Xxxxx Xxxxxx PhD
|
Name: | Xxxxxxx X. Xxxxxxxxx, M.D.
|
|||||||
Title:
|
Head of MRC Centre, Oxforshire
|
Title: | Chairman & CEO
|
|||||||
MRC Centre Oxfordshire | ||||||||||
MRC Xxxxxxx | ||||||||||
XXXXXX | ||||||||||
Xxxxxxxxxxx XX00 0XX | ||||||||||
Tel: 00000 000000 |
† | DESIGNATES PORTIONS OF THIS DOCUMENT THAT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT FILED SEPARATELY WITH THE COMMISSION |